Halozyme Therapeutics

-$0.79 (-1.91%) As of 7:47 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment.

CEO
Helen I. Torley
Employees
136
Headquarters
San Diego, California
Founded
1998

HALO Key Statistics

Market Cap
5.77B
Price-Earnings Ratio
36.45
Dividend Yield
—
Average Volume
855.12K
High Today
$41.55
Low Today
$40.54
Open Price
$41.55
Volume
366.81K
52 Week High
$56.40
52 Week Low
$25.17

HALO Earnings

-$0.24
$0.02
$0.27
$0.53
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure